Work

Harnessing the Tumor Suppressor Function of FOXO as an Alternative Therapeutic Approach in Cancer

Year: 2011

Type: article

Source: Current Drug Targets

DOI: 10.2174/138945011796150271

Authors: Amrik Singh, Jessica Plati, Roya Khosravi-Far

Institutions: Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: FOXO transcription factor regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: Training Program in Angiogenesis and Inflammation, A Training Program in Molecular Hematology, G60560544, G6099155148, Suppression of FOXO3a as a determinant in Bcr-Abl-mediated transformation, Tumor Selective Apoptosis by TRAIL, Oncogene-Induced Evasion from Apoptosis

OpenAlex ID: W1992785642

FWCI: 0.519

Cites:

Cited by: 16

Related to: 10